IDH1 and central nervous system cancer: Lower-grade gliomas, which most commonly have the isocitrate dehydrogenase 1 (IDH1) mutation, were investigated using hyperpolarized [1-13C] pyruvate MRSI and presented with a lower pyruvate-to-lactate conversion compared to GBM models.